Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis

The protective capabilities of three Leishmania recombinant proteins – histone 1 (H1) and hydrophilic acylated surface protein B1 (HASPB1) immunized singly, or together as a protein cocktail vaccine with Montanide™, and the polyprotein MML immunized with MPL(®)-SE adjuvant – were assessed in beagle...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, J., Nieto, J., Masina, S., Cañavate, C., Cruz, I., Chicharro, C., Carrillo, E., Napp, S., Reymond, C., Kaye, P.M., Smith, D.F., Fasel, N., Alvar, J.
Formato: Texto
Lenguaje:English
Publicado: Elsevier Science 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695600/
https://www.ncbi.nlm.nih.gov/pubmed/17576026
http://dx.doi.org/10.1016/j.vaccine.2007.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695600/
https://www.ncbi.nlm.nih.gov/pubmed/17576026
http://dx.doi.org/10.1016/j.vaccine.2007.05.010

Ejemplares similares